These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Monoclonal antibody F1 binds to the kringle domain of factor XII and induces enhanced susceptibility for cleavage by kallikrein. Ravon DM, Citarella F, Lubbers YT, Pascucci B, Hack CE. Blood; 1995 Dec 01; 86(11):4134-43. PubMed ID: 7492770 [Abstract] [Full Text] [Related]
6. Titanium is a potent inducer of contact activation: implications for intravascular devices. Litvak M, Shamanaev A, Zalawadiya S, Matafonov A, Kobrin A, Feener EP, Wallisch M, Tucker EI, McCarty OJT, Gailani D. J Thromb Haemost; 2023 May 01; 21(5):1200-1213. PubMed ID: 36696212 [Abstract] [Full Text] [Related]
7. Functional characterization of a variant factor XII (F XII Locarno) in a cross reacting material positive F XII deficient plasma. Wuillemin WA, Furlan M, Stricker H, Lämmle B. Thromb Haemost; 1992 Feb 03; 67(2):219-25. PubMed ID: 1621242 [Abstract] [Full Text] [Related]
8. Activation of factor XI in plasma is dependent on factor XII. Brunnée T, La Porta C, Reddigari SR, Salerno VM, Kaplan AP, Silverberg M. Blood; 1993 Feb 01; 81(3):580-6. PubMed ID: 8427954 [Abstract] [Full Text] [Related]
9. Activation of human blood coagulation factor XI independent of factor XII. Factor XI is activated by thrombin and factor XIa in the presence of negatively charged surfaces. Naito K, Fujikawa K. J Biol Chem; 1991 Apr 25; 266(12):7353-8. PubMed ID: 2019570 [Abstract] [Full Text] [Related]
10. Factor XII in coagulation, inflammation and beyond. Didiasova M, Wujak L, Schaefer L, Wygrecka M. Cell Signal; 2018 Nov 25; 51():257-265. PubMed ID: 30118759 [Abstract] [Full Text] [Related]
11. Factor XII promotes blood coagulation independent of factor XI in the presence of long-chain polyphosphates. Puy C, Tucker EI, Wong ZC, Gailani D, Smith SA, Choi SH, Morrissey JH, Gruber A, McCarty OJ. J Thromb Haemost; 2013 Jul 25; 11(7):1341-52. PubMed ID: 23659638 [Abstract] [Full Text] [Related]
12. Oral FXIIa inhibitor KV998086 suppresses FXIIa and single chain FXII mediated kallikrein kinin system activation. Clermont AC, Murugesan N, Edwards HJ, Lee DK, Bayliss NP, Duckworth EJ, Pethen SJ, Hampton SL, Gailani D, Feener EP. Front Pharmacol; 2023 Jul 25; 14():1287487. PubMed ID: 38178859 [Abstract] [Full Text] [Related]
13. The levels of factor XIIa generated in human plasma on an electronegative surface are insensitive to wide variation in the concentration of FXII, prekallikrein, high molecular weight kininogen or FXI. Mitropoulos KA. Thromb Haemost; 1999 Sep 25; 82(3):1033-40. PubMed ID: 10494760 [Abstract] [Full Text] [Related]
14. Factor XII contact activation can be prevented by targeting 2 unique patches in its epidermal growth factor-like 1 domain with a nanobody. Frunt R, El Otmani H, Smits S, Clark CC, Maas C. J Thromb Haemost; 2024 Sep 25; 22(9):2562-2575. PubMed ID: 38897387 [Abstract] [Full Text] [Related]
15. Enzymes produced by autoactivation of blood factor XII in buffer: A contribution from the Hematology at Biomaterial Interfaces Research Group. Golas A, Pitakjakpipop H, Rahn MS, Siedlecki CA, Vogler EA. Biomaterials; 2015 Jan 25; 37():1-12. PubMed ID: 25443791 [Abstract] [Full Text] [Related]
16. A mechanism for hereditary angioedema with normal C1 inhibitor: an inhibitory regulatory role for the factor XII heavy chain. Ivanov I, Matafonov A, Sun MF, Mohammed BM, Cheng Q, Dickeson SK, Kundu S, Verhamme IM, Gruber A, McCrae K, Gailani D. Blood; 2019 Mar 07; 133(10):1152-1163. PubMed ID: 30591525 [Abstract] [Full Text] [Related]
17. A site on factor XII required for productive interactions with polyphosphate. Shamanaev A, Litvak M, Cheng Q, Ponczek M, Dickeson SK, Smith SA, Morrissey JH, Gailani D. J Thromb Haemost; 2023 Jun 07; 21(6):1567-1579. PubMed ID: 36863563 [Abstract] [Full Text] [Related]
18. Coagulation factor XI improves host defence during murine pneumonia-derived sepsis independent of factor XII activation. Stroo I, Zeerleder S, Ding C, Luken BM, Roelofs JJTH, de Boer OJ, Meijers JCM, Castellino FJ, van 't Veer C, van der Poll T. Thromb Haemost; 2017 Jul 26; 117(8):1601-1614. PubMed ID: 28492700 [Abstract] [Full Text] [Related]
19. Cleavage of human high molecular weight kininogen markedly enhances its coagulant activity. Evidence that this molecule exists as a procofactor. Scott CF, Silver LD, Schapira M, Colman RW. J Clin Invest; 1984 Apr 26; 73(4):954-62. PubMed ID: 6561202 [Abstract] [Full Text] [Related]
20. The Fibronectin Type II Domain of Factor XII Ensures Zymogen Quiescence. Clark CC, Hofman ZLM, Sanrattana W, den Braven L, de Maat S, Maas C. Thromb Haemost; 2020 Mar 26; 120(3):400-411. PubMed ID: 31940673 [Abstract] [Full Text] [Related] Page: [Next] [New Search]